Marseille, 23 September 2026 – The Aix-Marseille-Provence Metropolitan Authority has handed over the keys to the LB3 building on the Luminy campus to MIB. This marks a new stage in the establishment of two of the biocluster’s technology platforms: B-Screen and Cell-Scale. These facilities will support the continued development of both platforms at the Luminy […]
Press release – MIB and Sanofi enter into a strategic partnership to accelerate the development of new immunology therapies
Marseille, 14 October 2026 – MIB and Sanofi held the first Steering and Monitoring Committee meeting of their Translational Centre of Excellence (TCOE) on 30 September 2026. This meeting marks a key milestone in the operational implementation of the strategic partnership signed in March 2026. The TCOE is designed as an operational framework enabling teams […]
MIB joins the France Biotech network
Marseille, 9 october 2026 – Aix-Marseille Université, the coordinating institution of the Marseille Immunology Biocluster (MIB) consortium, has joined France Biotech. This membership will enable MIB to take part in national discussions on the development of companies innovating in healthcare and strengthen its links with organisations across the sector. An independent association, France Biotech brings […]
MIB Startup Studio: First Cohort Kicks Off
Marseille, 5 october 2026 – The first MIB Startup Studio cohort began its programme with two days of discussions bringing together startup founders, biotech entrepreneurs, mentors and regulatory experts. The aim was to get to know one another, share experiences and start discussing the projects. Therapeutic antibody engineering, bacterial and viral immunotherapies, discovery of new […]
SAB Voices: Erika Pearce – Reprogramming Immunity Through Metabolism
Marseille, 29 September 2026 – Prof. Erika Pearce still remembers when immunology began to feel less like a subject and more like a revelation. As a third-year undergraduate student, she enrolled in an immunology course with little prior exposure to the field beyond the everyday encounters most people have with medicine, such as doctor visits […]
Why autoimmune diseases are the next frontier of immunology
Marseille, September 27, 2026 – For decades, patients with autoimmune diseases were expected to manage them for life. Treatments improved and symptoms could be controlled for many, but eliminating the disease remained largely out of reach. In recent years, that expectation has been shifting. There has been tremendous progress done to keep autoimmune diseases at […]
SAB Voices: Jean-Daniel Lelièvre Thinks Everyone Does Immunology Without Knowing It
Marseille, 13 August 2026 – Prof. Jean-Daniel Lelièvre, a member of Marseille Immunology Biocluster’s Scientific Advisory Board, didn’t initially imagine a life in medicine. He came from a family of artists, with a father, grandfather and brother trained at the Beaux-Arts, and once considered an artistic path himself. Medicine came later, first through an interest […]
MIB Startup Studio launches its first call for applications to support immunology startups
Marseille, 6 July 2026 – Marseille Immunology Biocluster has launched the first call for applications for MIB Startup Studio, an initiative designed to support immunology startups in their scientific, strategic and entrepreneurial development. Created to support high-potential projects, MIB Startup Studio is aimed at established startups seeking to accelerate their development by connecting with a […]
SAB Voices: Pedro Romero on Why Marseille is Becoming a Hub for Translational Immunology
Marseille, 30 June 2026 – Professor Pedro Romero, the chair of the Scientific Advisory Board of Marseille Immunology Biocluster, once thought his future lay in nuclear physics. Growing up in Colombia, he was fascinated by fundamental science and initially imagined a career studying particles and reactors. But there was a practical problem. Colombia didn’t have […]
MIB joins France BioLead to strengthen France’s biomanufacturing ecosystem for biomedicines
Marseille, July 2026 – Marseille Immunology Biocluster has become a member of France BioLead, the national accelerator and representative of France’s biomanufacturing ecosystem for biomedicines. This membership marks an important step in MIB’s commitment to strengthening a sovereign, innovative and collaborative healthcare ecosystem in France. It places the biocluster within a national momentum aimed at […]